AI accelerates drug repurposing to find potential COVID-19 therapies: GlobalData
AI start-ups are helping pharma companies to digitally bridge the gap between thousands of repurposed drug molecules, clinical…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
drug development
CARE consortium launched to fast-track discovery and development of medicines to treat COVID-19
The CARE consortium comprises 37 teams from academic and non-profit research institutions and pharma companies
Race to find a viable vaccine: Can Indian firms rise to the challenge?
Juilee Dandekar, Sector Expert - Healthcare, Business Research & Advisory, Aranca gives an overview of India’s capabilities to…
Piramal Pharma Solutions to provide Bolt Biotherapeutics with immune-stimulating antibody conjugates…
Bolt’s Boltbody Immune Stimulating Antibody Conjugate (ISAC), BDC-1001, is currently in a first-in-human Phase 1/2 clinical study…
Genetics has revolutionised patient selection for clinical trials
Genetics is questioning the wisdom behind the old gold standard of randomised populations used for trials. While large randomised…
Chemistry experts develop small crystals from nanoscale encapsulated droplets
The new technique involving the use of inert oils to control evaporative solvent loss can unlock the potential of accelerated new…
‘We believe our effort will result in a broad-spectrum antiviral to address future outbreaks’
Dr Nir London, Senior Scientist, Department of Organic Chemistry, The Weizmann Institute of Science, has brought together a wide…
‘Directing’ evolution to identify potential drugs earlier in discovery
New research from an eight-year collaboration between scientists at the University of Leeds and the biopharmaceutical company…
Encouraging patient-centric innovation in pharma
Dr Ayaaz Hussain Khan, Global Head Generics, Navitas Life Sciences (a TAKE Solutions Enterprise) emphasises that patient…